Skip to main content
placeholder image

The A2A receptor agonist CGS 21680 has beneficial and adverse effects on disease development in a humanised mouse model of graft-versus-host disease

Journal Article


Abstract


Publication Date


  • 2019

Citation


  • Geraghty, N. J., Adhikary, S. R., Watson, D. & Sluyter, R. (2019). The A2A receptor agonist CGS 21680 has beneficial and adverse effects on disease development in a humanised mouse model of graft-versus-host disease. International Immunopharmacology, 72 479-486.

Scopus Eid


  • 2-s2.0-85064907120

Number Of Pages


  • 7

Start Page


  • 479

End Page


  • 486

Volume


  • 72

Place Of Publication


  • United Kingdom

Abstract


Publication Date


  • 2019

Citation


  • Geraghty, N. J., Adhikary, S. R., Watson, D. & Sluyter, R. (2019). The A2A receptor agonist CGS 21680 has beneficial and adverse effects on disease development in a humanised mouse model of graft-versus-host disease. International Immunopharmacology, 72 479-486.

Scopus Eid


  • 2-s2.0-85064907120

Number Of Pages


  • 7

Start Page


  • 479

End Page


  • 486

Volume


  • 72

Place Of Publication


  • United Kingdom